Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative inhaled penehyclidine for prevention of postoperative pulmonary complications in high-risk surgical patients
ChiCTR-IPC-15006603Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative respiratory complications (PRC) comparing Penehyclidine hydrochloride with Placebo control (2 arms). Primary endpoint: Postoperative pulmonary complications. Started Sep 2015; status: completed.
02
Drugs
penehyclidine
03
Conditions
postoperative respiratory complications (PRC)
Beyond the preview
Go deeper on ChiCTR-IPC-15006603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-15006603.